AILENE NIELSEN: Open Payments
NPI 1770542839 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,429 in 34 payments from 11 companies in 2025. Trend: 2023 $607 · 2024 $1,444 · 2025 $2,429
Food & beverage: $1,781Travel & lodging: $649
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 13 | $1,147 |
| AstraZeneca Pharmaceuticals LP | 2 | $258 |
| Amgen Inc. | 2 | $225 |
| BridgeBio Pharma, Inc. | 3 | $199 |
| E.R. Squibb & Sons, L.L.C. | 6 | $188 |
| ABIOMED | 1 | $148 |
| HEARTFLOW, INC. | 1 | $146 |
| SCPHARMACEUTICALS INC. | 2 | $38 |
| Edwards Lifesciences Corporation | 2 | $36 |
| CARDIVA MEDICAL, INC. | 1 | $28 |
Products named: REPATHA, Attruby, SYMPLICITY G3, CAMZYOS, FFRct, WAINUA, ELIQUIS, FUROSCIX.
Industry payments across NE — which companies pay providers there.
